403
Participants
Start Date
September 30, 2003
Primary Completion Date
May 31, 2008
Study Completion Date
May 31, 2008
Esomeprazole
Proton pump inhibitor 40 mg orally twice daily
Placebo proton pump inhibitor
Placebo proton pump inhibitor
NYU School of Medicine, New York
New York Medical College, Valhalla
North Shore-LIJ Medical Center, New Hyde Park
Thomas Jefferson Hospital Pulmonary Lab, Philadelphia
Duke University, Durham
Emory University, Atlanta
Nemours Childrens Clinic, Jacksonville
University of Miami, Miami
University of Alabama at Birmingham, Birmingham
Ohio State University, Columbus
Indiana University ACRC, Indianapolis
University of Minnesota, Minneapolis
Northwestern Memorial Hospital, Chicago
Univ of MO Kansas City School of Medicine, Kansas City
LSUHSC Pulmonary Critical Care, New Orleans
National Jewish Medical and Research Center, Denver
University of California, San Diego, San Diego
Washington University School of Medicine, St Louis
Baylor College of Medicine, Houston
Northern New England Consortium, Colchester
American Lung Association Asthma Clinical Research Centers
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Johns Hopkins Bloomberg School of Public Health
OTHER